Dishman Carbogen Amcis Reports Mixed Financial Results Amid Rising Interest Expenses in December 2024

Feb 13 2025 10:37 AM IST
share
Share Via
Dishman Carbogen Amcis has announced its financial results for the quarter ending December 2024, showing significant year-on-year growth in both Profit Before Tax and Profit After Tax. However, the company faces challenges, including increased interest expenses and a declining Debtors Turnover Ratio, indicating mixed performance in the pharmaceuticals sector.
Dishman Carbogen Amcis has recently reported its financial results for the quarter ending December 2024, revealing a complex picture of performance within the pharmaceuticals and drugs industry. The company's score has undergone an adjustment in evaluation, reflecting a notable shift from the previous assessment.

On the positive side, the Profit Before Tax (PBT) for the quarter stands at Rs 19.38 crore, showcasing a significant year-on-year growth of 126.79%. Similarly, the Profit After Tax (PAT) has reached Rs 4.28 crore, marking a robust year-on-year increase of 107.2%. These figures indicate a favorable near-term trend in profitability.

Conversely, the financial results also highlight challenges for Dishman Carbogen. The interest expense has risen to Rs 48.78 crore, representing a quarter-on-quarter growth of 33.17%. This increase suggests a reliance on borrowing, as evidenced by the debt-equity ratio, which has reached its highest level at 0.44 times over the past five half-year periods. Additionally, the Debtors Turnover Ratio has declined to 3.71 times, indicating a slower pace in settling receivables.

Overall, Dishman Carbogen's recent financial results present a mixed landscape of growth and challenges.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News